Mesenteritis stwardniająca
Diagnostyka i diagnoza

Sclerosing mesenteritis (SM) to rzadkie, idiopatyczne zapalenie tkanki tłuszczowej krezki jelita cienkiego, charakteryzujące się procesami zapalnymi, martwicą tłuszczową i włóknieniem. Częstość występowania wynosi poniżej 1%. Klinicznie objawia się niespecyficznie, z dominującym bólem brzucha (78,1%), gorączką (26%), utratą masy ciała (22,9%) oraz objawami ze strony przewodu pokarmowego, takimi jak biegunka (19,3%) czy wymioty (18,2%). W badaniu fizykalnym możliwe jest wyczucie guza w górnej części brzucha (15-50%) oraz objawy niedrożności jelit (24%). Diagnostyka opiera się na badaniach obrazowych, głównie tomografii komputerowej (TK), gdzie stosuje się kryteria Couliera – rozpoznanie wymaga obecności co najmniej 3 spośród charakterystycznych cech, takich jak mglisty wygląd krezki, obecność guza krezki, niejednorodna gęstość tłuszczu, obecność małych węzłów do 10 mm, objaw pierścienia tłuszczowego („fat ring sign”) oraz pseudotorebka. Dodatkowo, w około 80% przypadków obserwuje się podwyższone markery stanu zapalnego, takie jak CRP i OB.

Diagnostyka ogólna Sclerosing Mesenteritis

Sclerosing mesenteritis (SM) jest rzadkim idiopatycznym schorzeniem zapalnym, dotyczącym tkanki tłuszczowej krezki jelita cienkiego, z częstością występowania szacowaną na mniej niż 1% populacji ogólnej.12 Charakteryzuje się obecnością procesów zapalnych, martwicy tłuszczowej i włóknienia.3 Diagnostyka tego schorzenia jest złożona, głównie ze względu na niespecyficzne objawy kliniczne oraz podobieństwo obrazu radiologicznego do innych chorób, w tym nowotworów.

W diagnostyce sclerosing mesenteritis stosuje się zarówno badania kliniczne, obrazowe, jak i histopatologiczne. Badania obrazowe stanowią podstawę rozpoznania, jednak ostateczna diagnoza często wymaga potwierdzenia histopatologicznego poprzez biopsję.34 Około 15% pacjentów może być całkowicie bezobjawowych, a schorzenie wykrywa się przypadkowo podczas badań obrazowych wykonywanych z innych powodów.1

Objawy kliniczne i badanie fizykalne

Objawy sclerosing mesenteritis są niespecyficzne, co utrudnia postawienie prawidłowej diagnozy. Najczęstszymi dolegliwościami zgłaszanymi przez pacjentów są:12

  • Ból brzucha (78,1% przypadków)
  • Gorączka (26%)
  • Utrata masy ciała (22,9%)
  • Biegunka (19,3%)
  • Wymioty (18,2%)
  • Anoreksja (13,5%)
  • Zaparcia (10,9%)
  • Wzdęcia (9,4%)
  • Osłabienie (5,7%)
  • Nudności (5,7%)
  • Ból podczas jedzenia (4,7%)
  • Zmęczenie (2,1%)

12

Podczas badania fizykalnego, szczególnie istotne jest dokładne badanie palpacyjne jamy brzusznej. Sclerosing mesenteritis często formuje wyczuwalny guz w górnej części brzucha, który może być wykryty podczas badania palpacyjnego.56 W niektórych przypadkach można zaobserwować objawy niedrożności jelit (24% przypadków) oraz wyczuwalny guz brzuszny (15-50% przypadków).7

Badania laboratoryjne

Nie istnieją specyficzne biomarkery laboratoryjne dla rozpoznania sclerosing mesenteritis. Jednak u około 80% pacjentów obserwuje się podwyższone markery stanu zapalnego, takie jak:89

Badania laboratoryjne są często prawidłowe lub wykazują niewielkie, niespecyficzne odchylenia w zależności od nasilenia procesu chorobowego.10 W przypadku podejrzenia sclerosing mesenteritis ważne jest wykluczenie innych schorzeń, które mogą dawać podobne objawy, w tym nowotworów (chłoniaki, guzy neuroendokrynne) oraz chorób autoimmunologicznych.

Diagnostyka obrazowa

Badania obrazowe odgrywają kluczową rolę w diagnostyce sclerosing mesenteritis. Rozwój technologii obrazowania, zwłaszcza tomografii komputerowej (TK), znacząco poprawił częstość rozpoznawania tej choroby.89

Tomografia komputerowa (TK)

Tomografia komputerowa jest najczęściej stosowaną metodą obrazowania w diagnostyce sclerosing mesenteritis. Charakterystyczne cechy obrazu TK obejmują:1112

  • „Misty mesentery” (mglisty wygląd krezki) – zwiększona gęstość tkanki tłuszczowej krezki, co stanowi pierwsze, choć niespecyficzne, wskazanie na SM
  • Obecność guza krezki, który odgranicza i przemieszcza okoliczne struktury bez ich naciekania
  • Niejednorodna gęstość tłuszczu w obrębie masy, o większej gęstości niż sąsiadująca tkanka tłuszczowa zaotrzewnowa lub krezki okrężnicy
  • Obecność małych węzłów tkanki miękkiej, typowo o wielkości do 10 mm
  • „Fat ring sign” (objaw pierścienia tłuszczowego) – niskodensyjny otoczką tłuszczową wokół węzłów chłonnych lub naczyń krezki (występuje w 75-90% przypadków)
  • Pseudotorebka o zwiększonej gęstości, która może otaczać zajęty obszar (50-60% przypadków)
  • Obecność zwłóknień w obrębie zapalnej tkanki tłuszczowej, widocznych jako pasma o gęstości tkanki miękkiej
  • Mogą występować punktowe lub grube zwapnienia

111314

Do rozpoznania sclerosing mesenteritis w badaniu TK można wykorzystać kryteria Couliera. Diagnozę można postawić, gdy obecne są co najmniej 3 z powyższych kryteriów.11 Warto zaznaczyć, że podgrupa pacjentów z zapaleniem krezki i histologicznie potwierdzonym SM może mieć rozległe zmiany radiologiczne, które nie spełniają kryteriów Couliera dla zapalenia krezki (mesenteric panniculitis).1516

Rezonans magnetyczny (MR)

Badanie rezonansu magnetycznego również znajduje zastosowanie w diagnostyce sclerosing mesenteritis, choć dostępnych jest mniej standaryzowanych kryteriów w porównaniu do TK.17 W obrazowaniu MR sclerosing mesenteritis charakteryzuje się:18

  • Pośrednią intensywnością sygnału w obrazach T1-zależnych
  • Zmienną intensywnością sygnału w obrazach T2-zależnych, zależną od stopnia obrzęku i włóknienia:
    • Obecność obrzęku powoduje wysoki sygnał w T2
    • Włóknienie powoduje niski sygnał w T2

Badanie ultrasonograficzne (USG)

Badanie ultrasonograficzne może być pomocne w diagnostyce sclerosing mesenteritis, choć jest rzadziej stosowane niż TK czy MR. W obrazie USG sclerosing mesenteritis przedstawia się jako:19

  • Heterogenna masa z przewagą zarówno hipoechogenicznych, jak i hiperechogenicznych cech

Ostatnie badania sugerują, że USG może być czułą, wiarygodną i nieinwazyjną metodą zarówno w diagnostyce, jak i w monitorowaniu przebiegu SM.317

PET-CT

Badanie PET-CT (pozytonowa tomografia emisyjna połączona z tomografią komputerową) z wykorzystaniem 18F-fluorodeoksyglukozy (18F-FDG) może być przydatne w różnicowaniu sclerosing mesenteritis od złośliwego zajęcia krezki.11 Wyniki niedawno opublikowanych badań wskazują, że badanie PET pozwala klinicystom na odróżnienie łagodnych procesów krezki od procesów nowotworowych.20

Diagnostyka histopatologiczna

Mimo że badania obrazowe są istotne w diagnostyce sclerosing mesenteritis, ostateczne rozpoznanie często wymaga potwierdzenia histopatologicznego.313 Biopsja jest szczególnie ważna w celu wykluczenia innych chorób, zwłaszcza nowotworów, takich jak chłoniak czy rakowiak.56

Metody pobierania materiału biopsyjnego

Materiał do badania histopatologicznego można uzyskać na kilka sposobów:56

  • Biopsja chirurgiczna – często wykonywana w przypadku niejednoznacznych wyników badań obrazowych lub gdy istnieje konieczność leczenia operacyjnego
  • Biopsja przezskórna pod kontrolą TK – mniej inwazyjna metoda, stosowana gdy zmiana jest dostępna do nakłucia

Biorąc pod uwagę szerokie różnicowanie i podobne obrazy radiologiczne kilku procesów nowotworowych, znaczna liczba pacjentów zazwyczaj wymaga biopsji pod kontrolą TK w celu ustalenia diagnozy.421

Cechy histopatologiczne

W badaniu histopatologicznym sclerosing mesenteritis charakteryzuje się:22

  • Włóknieniem
  • Obecnością miofibroblastów
  • Naciekiem komórek zapalnych w tkance tłuszczowej z degeneracją lub martwicą tłuszczu
  • Agregacją makrofagów wypełnionych lipidami (lipofagów)

W zależności od dominującego obrazu histopatologicznego, sclerosing mesenteritis można podzielić na trzy kategorie:423

  • Mesenteric panniculitis (zapalenie krezki) – faza ostra lub podostra, w której dominuje degeneracja tłuszczowa i zapalenie
  • Retractile mesenteritis (kurczliwe zapalenie krezki) – forma przewlekła, w której dominuje włóknienie
  • Sclerosing mesenteritis (stwardniające zapalenie krezki) – włóknista faza zapalenia krezki

Wciąż trwa debata kliniczna, czy sclerosing mesenteritis reprezentuje trzy różne mikroskopowe jednostki patologiczne, czy tylko dwie.89

Diagnostyka różnicowa

Ze względu na niespecyficzny obraz kliniczny i radiologiczny, sclerosing mesenteritis wymaga różnicowania z wieloma innymi schorzeniami, zwłaszcza z procesami nowotworowymi.1424

Nowotwory i procesy nowotworopodobne

Główne jednostki chorobowe wymagające różnicowania z sclerosing mesenteritis to:251426

  • Chłoniak – najczęstszy nowotwór zajmujący krezkę, szczególnie trudny do różnicowania we wczesnym stadium, gdy masywna limfadenopatia może być jeszcze nieobecna
  • Guz rakowiakowy (carcinoid) – obraz TK może być identyczny jak w SM; zarówno SM, jak i rakowiak mogą pojawiać się jako naciekająca masa w korzeniu krezki z reakcją desmoplastyczną i zwapnieniami
  • Przerzuty do krezki
  • Mięsaki tkanek miękkich
  • Włókniakowatość krezki (mesenteric fibromatosis)
  • GIST (nowotwór podścieliskowy przewodu pokarmowego)
  • Zrakowaciały międzybłoniak otrzewnej (peritoneal carcinomatosis)

Inne schorzenia

Poza nowotworami, sclerosing mesenteritis należy różnicować z:2714

  • Chorobą Webera-Christiana
  • Włóknieniem zaotrzewnowym (retroperitoneal fibrosis)
  • Chorobami zakaźnymi (gruźlica, histoplazmoza)
  • Amyloidozą
  • Chorobami zapalnymi jelit
  • Zapaleniem trzustki
  • Chorobami autoimmunologicznymi
  • Chorobami związanymi z IgG4

Rozpoznanie sclerosing mesenteritis jest często diagnozą z wykluczenia, po wykluczeniu innych, częstszych przyczyn zmian w obrębie krezki.28 W przypadku pacjentów z historią choroby nowotworowej, konieczne jest wycięcie i zbadanie guzków krezki, aby odróżnić nawrót guza od alternatywnych rozpoznań, takich jak sclerosing mesenteritis.20

Tabela 1. Charakterystyka kliniczna i epidemiologiczna sclerosing mesenteritis na podstawie wybranych badań
Cecha Badanie Durst (1977) Badanie Emory (1997) Badanie Akram (2007)
Rodzaj badania Skumulowane dane z literatury Retrospektywne, jednoośrodkowe Retrospektywne, jednoośrodkowe
Okres badania 1955-1972 1970-1993 1982-2005
Liczba przypadków 68 84 92
Wiek w momencie diagnozy (zakres) 53 (7-82) 60 (23-87) Mediana 64,5 (IQR 55-72)
Stosunek mężczyzn do kobiet 1,8:1 1,9:1 2,3:1
Wcześniejsza operacja brzuszna/uraz (%) 12 (18%) 4/78 (5%) 32 (35%)
Choroby reumatologiczne (%) Brak danych 1/78 (1,2%) 5 (6%)
Włóknienie w innych miejscach (%) Brak danych 4 (5%) 4 (4%)
Czas trwania objawów (zakres) Brak danych 12 miesięcy (dni do 10 lat) Brak danych
Ból brzucha (%) 46 (68%) 27/78 (35%) 65 (70%)
Biegunka lub zaparcia (%) 11 (16%) Brak danych 33 (41%)
Wzdęcia/rozdęcie (%) Brak danych Brak danych 24 (26%)
Utrata masy ciała (%) 10 (15%) Brak danych 21 (23%)
Nudności i wymioty (%) 22 (32%) Brak danych 18 (21%)
Gorączka (%) 11 (16%) Brak danych 5 (6%)
Wyczuwalny guz brzuszny (%) 34 (50%) 24/78 (31%) 14 (15%)
Objawy niedrożności jelit (%) 22 (32%) 24/78 (31%) 22 (24%)
Podwyższone OB (%) Brak danych Brak danych 13 (14%)
Jednoczesna inna patologia wewnątrzbrzuszna (%) 17 (25%) Brak danych 17 (18%)
Choroba złośliwa (%) 4 (6%) Brak danych 7 (8%)
Choroba niezłośliwa (%) 13 (19%) Brak danych 10 (10%)

7

Kryteria diagnostyczne

Nie istnieją powszechnie przyjęte standaryzowane kryteria diagnostyczne dla sclerosing mesenteritis. Jednak niektóre badania proponują kryteria oparte na wynikach radiologicznych i histopatologicznych:13

  • Zmiany o gęstości tłuszczowej, które tworzą pojedyncze, mnogie lub rozlane masy
  • Histologiczne potwierdzenie martwicy tłuszczowej z naciekiem zapalnym i/lub naciekiem przez makrofagi
  • Brak dowodów na chorobę zapalną jelit, zapalenie trzustki lub martwicę tłuszczu pozaotrzewnowego (sugerującą chorobę Webera-Christiana)

Kryteria Couliera do rozpoznania sclerosing mesenteritis w badaniu TK obejmują obecność co najmniej 3 z następujących cech:11

  • Masa krezki, która odgranicza i przemieszcza okoliczne struktury bez ich naciekania
  • Niejednorodna gęstość tłuszczu w obrębie masy, o większej gęstości niż sąsiadująca tkanka tłuszczowa zaotrzewnowa lub krezki okrężnicy
  • Zawiera małe węzły tkanki miękkiej, typowo o wielkości do 10 mm
  • Niskodensyjna otoczka tłuszczowa („halo sign”) wokół węzłów chłonnych lub naczyń krezki
  • Pseudotorebka o zwiększonej gęstości, która może otaczać zajęty obszar przy braku wodobrzusza lub znanego nowotworu zajmującego krezkę

Podsumowanie procesu diagnostycznego

Diagnostyka sclerosing mesenteritis jest złożona i często wymaga zastosowania wielu metod. Proces diagnostyczny zwykle obejmuje:895

  1. Szczegółowy wywiad lekarski i badanie fizykalne
  2. Badania laboratoryjne, w tym markery stanu zapalnego
  3. Badania obrazowe, z preferencją TK, ewentualnie MR lub USG
  4. W przypadku niejednoznacznych wyników lub konieczności wykluczenia procesu nowotworowego – biopsję z badaniem histopatologicznym

Diagnoza sclerosing mesenteritis często pozostaje rozpoznaniem z wykluczenia, po wykluczeniu innych, częstszych przyczyn zmian w obrębie krezki.28 W przypadku pacjentów z historią choroby nowotworowej lub podejrzeniem nowotworu, biopsja jest często niezbędna do ustalenia prawidłowego rozpoznania.24

Rola poszczególnych metod diagnostycznych może się różnić w zależności od konkretnego przypadku klinicznego i dostępności zaawansowanych technik obrazowania. W praktyce klinicznej, diagnoza jest często stawiana na podstawie kombinacji obrazu klinicznego, radiologicznego i – gdy to możliwe – histopatologicznego.2926

Wczesne rozpoznanie sclerosing mesenteritis jest kluczowe dla optymalizacji leczenia i poprawy rokowania pacjentów.3031 Szybka i dokładna diagnoza zapewnia pacjentom otrzymanie odpowiedniego leczenia i zapobiega potencjalnym powikłaniom.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Sclerosing mesenteritis: a comprehensive clinical review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6174187/
    Sclerosing mesenteritis is a rare disease entity initially described in 1924 with a prevalence reported to be less than 1%. […] The purpose of this article is to provide an overview of the literature relevant to the diagnosis, etiology, and management of this condition in hopes of making physicians aware of this unique condition. […] Symptoms of sclerosing mesenteritis are non-specific, and up to 15% of patients can even be completely asymptomatic when it is found on the imaging performed for some other reasons. […] The initial case series published in the early 1950s did include a large proportion of patients who were diagnosed with sclerosing mesenteritis because of abnormal physical examination findings suggestive of abdominal masses. […] A recently published systematic review of 192 cases of sclerosing mesenteritis revealed the symptomatology as abdominal pain in 78.1%, fever 26.0%, weight loss 22.9%, diarrhea 19.3%, vomiting 18.2%, anorexia 13.5%, constipation 10.9%, bloating 9.4%, malaise 5.7%, nausea 5.7%, pain with eating 4.7%, and fatigue 2.1% of patients.
  • #2 Sclerosing mesenteritis: a comprehensive clinical review
    https://atm.amegroups.org/article/view/20473/html
    Sclerosing mesenteritis is a rare disease entity initially described in 1924 with a prevalence reported to be less than 1%. […] The purpose of this article is to provide an overview of the literature relevant to the diagnosis, etiology, and management of this condition in hopes of making physicians aware of this unique condition. […] Symptoms of sclerosing mesenteritis are non-specific, and up to 15% of patients can even be completely asymptomatic when it is found on the imaging performed for some other reasons. […] The most common presenting complaint is abdominal pain. […] A recently published systematic review of 192 cases of sclerosing mesenteritis revealed the symptomatology as abdominal pain in 78.1%, fever 26.0%, weight loss 22.9%, diarrhea 19.3%, vomiting 18.2%, anorexia 13.5%, constipation 10.9%, bloating 9.4%, malaise 5.7%, nausea 5.7%, pain with eating 4.7%, and fatigue 2.1% of patients.
  • #3 Ultrasonography-Based Management of Sclerosing Mesenteritis: From Diagnosis to Follow-Up
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8009549/
    Sclerosing mesenteritis (SM) is an idiopathic disorder affecting mesentery, characterized by fat necrosis, chronic inflammation and fibrosis. The diagnosis is suggested by imaging but can be definitely established only by biopsies. […] Taking into account its non-specific manifestations, radiologic imaging plays a key role in the diagnosis of SM; nevertheless, a definite diagnosis can be established only by surgical or imaging-guided biopsies. […] The detection at CT scan of an increase in the mesenteric fat density, named misty mesentery, should be considered the first indication, but non-specific mark of SM. […] Furthermore, US and magnetic resonance imaging (MRI) have also been performed for the diagnosis of SM, but there are fewer studies for these procedures than CT and lack of standardized criteria. […] In conclusion, US could be a sensitive, reliable and non-invasive procedure for the diagnosis and the follow-up of SM.
  • #4 Sclerosing mesenteritis: a comprehensive clinical review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6174187/
    Although no definitive gross pathologic criteria have been defined, Kipfer et al. proposed the sclerosing mesenteritis to have three gross pathological clinical categories. […] Given the broad differential and the similar imaging findings of several neoplastic processes, a significant number of patients usually undergo CT guided biopsy to establish the diagnosis. […] A significant variety of medical interventions have been used and reported in the literature to treat this challenging diagnosis. […] In one of the largest studies published to date by Akram et al., they proposed a medical treatment algorithm of using tamoxifen twice daily and a prednisone taper completed over three months.
  • #5 Sclerosing mesenteritis // Middlesex Health
    https://middlesexhealth.org/learning-center/diseases-and-conditions/sclerosing-mesenteritis
    Tests and procedures used to diagnose sclerosing mesenteritis include: […] During a physical exam, a member of your healthcare team looks for clues that may help find a diagnosis. For instance, sclerosing mesenteritis often forms a mass in the upper abdomen that can be felt during a physical exam. […] Imaging tests of the abdomen may show sclerosing mesenteritis. Imaging tests may include computerized tomography (CT) or magnetic resonance imaging (MRI). […] If you’re experiencing sclerosing mesenteritis symptoms, a biopsy may be needed to rule out other diseases and to make a definitive diagnosis. A biopsy sample may be collected during surgery or by inserting a long needle through the skin. […] Before starting treatment, a biopsy can confirm the diagnosis and rule out other possibilities, including certain cancers such as lymphoma and carcinoid.
  • #6 Sclerosing mesenteritis | Health Library | Memorial Health System
    https://www.mhsystem.org/health-library/con-20213811/
    Sclerosing mesenteritis is a condition in which tissue that holds the small intestines in place, called the mesentery, becomes inflamed and forms scar tissue. […] Tests and procedures used to diagnose sclerosing mesenteritis include: […] During a physical exam, a member of your healthcare team looks for clues that may help find a diagnosis. For instance, sclerosing mesenteritis often forms a mass in the upper abdomen that can be felt during a physical exam. […] Imaging tests of the abdomen may show sclerosing mesenteritis. Imaging tests may include computerized tomography (CT) or magnetic resonance imaging (MRI). […] If you’re experiencing sclerosing mesenteritis symptoms, a biopsy may be needed to rule out other diseases and to make a definitive diagnosis. A biopsy sample may be collected during surgery or by inserting a long needle through the skin. […] Before starting treatment, a biopsy can confirm the diagnosis and rule out other possibilities, including certain cancers such as lymphoma and carcinoid.
  • #7 Sclerosing Mesenteritis | Abdominal Key
    https://abdominalkey.com/sclerosing-mesenteritis/
    Characteristic Durst [13] Emory [15] Akram [1] Year of publication 1977 1997 2007 Study design Cumulative literature dataa Retrospective, single-centerb Retrospective, single-centerc Study period 19551972 19701993 19822005 No. of cases 68 84 92 Age at diagnosis, yr (range) 53 (782) 60 (2387) Median 64.5 (IQR 5572) Malefemale ratio 1.8:1 1.9:1 2.3:1 Previous abdominal surgery/trauma, n (%) 12 (18) 4/78 (5) 32 (35) Associated conditions, n (%) Rheumatologic disorders N/A 1/78 (1.2) 5 (6) Fibrosis at other sites N/Ad 4 (5) 4 (4) Duration of symptoms, mo (range) N/A (24 h to 2 years) 12 (days to 10 years) N/A Symptoms, n (%) Abdominal pain 46 (68) 27/78 (35) 65 (70) Diarrhea or constipation 11 (16) N/A 33 (41) Bloating/distension N/A N/A 24 (26) Weight loss 10 (15) N/A 21 (23) Nausea and vomiting 22 (32) N/A 18 (21) Fever 11 (16) N/A 5 (6) Physical examination, n (%) Palpable abdominal mass 34 (50) 24/78 (31) 14 (15) Signs of bowel obstruction 22 (32) 24/78 (31) 22 (24) Elevated ESR, n (%) N/A N/A 13 (14) Concurrent other intra-abdominal pathology 17 (25) N/A 17 (18) Malignant disease 4 (6) N/A 7 (8) Nonmalignant disease 13 (19) N/A 10 (10)
  • #8 Sclerosing mesenteritis: a comprehensive clinical review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6174187/
    There is no specific laboratory biomarker/test available for the diagnosis of sclerosing mesenteritis although the elevation in inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) has been reported in as high as in 80% of cases. […] Abdominal imaging is the mainstay for the diagnosis of the sclerosing mesenteritis, and the advent of CT scan has drastically improved the diagnostic incidence of sclerosing mesenteritis. […] One of the specific CT scan signs to diagnosis sclerosing mesenteritis is a fat ring sign but presence of pseudo-capsule also raise the suspicion of sclerosing mesenteritis. […] The clinical debate that has persisted pertains to whether sclerosing mesenteritis is representative of three different microscopic pathologic entities or just two.
  • #9 Sclerosing mesenteritis: a comprehensive clinical review
    https://atm.amegroups.org/article/view/20473/html
    There is no specific laboratory biomarker/test available for the diagnosis of sclerosing mesenteritis although the elevation in inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) has been reported in as high as in 80% of cases. […] Abdominal imaging is the mainstay for the diagnosis of the sclerosing mesenteritis, and the advent of CT scan has drastically improved the diagnostic incidence of sclerosing mesenteritis. […] One of the specific CT scan signs to diagnosis sclerosing mesenteritis is a fat ring sign but presence of pseudo-capsule also raise the suspicion of sclerosing mesenteritis. […] The clinical debate that has persisted pertains to whether sclerosing mesenteritis is representative of three different microscopic pathologic entities or just two.
  • #10 Sclerosing Mesenteritis-Update on Diagnostic and Therapeutic Appr
    https://www.itmedicalteam.pl/articles/sclerosing-mesenteritisupdate-on-diagnostic-and-therapeutic-approach-108510.html
    Sclerosing mesenteritis (SM) is a rare, non-specific inflammatory condition, mainly affecting the benign intestinal mesentery. […] The radiological study, especially computed tomography (CT) and magnetic resonance imaging (MRI) are essential components in the diagnostic evaluation. […] The diagnosis is established by histopathologic study. […] The clinical presentation of SM is varied and its diagnosis requires a high degree of suspicion, because the disease is usually asymptomatic. […] The major signs and symptoms appear to be associated with inflammation and the adjacent organ mass effect. […] The laboratory tests are often normal or discrete non-specific variations feature depending on the seriousness of the painting. […] The radiological study, particularly CT and MRI, are essential components in the diagnostic evaluation, though many of its features are nonspecific.
  • #11 Sclerosing mesenteritis | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/sclerosing-mesenteritis-1?embed_domain=hackmd.io%25252F%252540yIPUAFeCSL2JsU8smR5nJQ%25252Fbnjhjgjghjghjghfavicon.ico&lang=us
    Sclerosing mesenteritis, also known as mesenteric panniculitis or retractile mesenteritis, is an uncommon idiopathic disorder characterized by chronic non-specific inflammation involving the adipose tissue of the bowel mesentery. […] The Coulier criteria can be used to diagnose sclerosing mesenteritis on CT when 3 of the following criteria are present: mesenteric mass which defines and displaces nearby structures without invading them, inhomogenous fat density within the mass attenuates higher than adjacent retroperitoneal or meso-colonic fat, contains small soft tissue nodes, typically 10 mm, low attenuation fatty „halo sign” surrounds lymph nodes or mesenteric vessels, hyperattenuating pseudocapsule may surround the affected area in the absence of ascites or known malignancy involving the mesentery. […] FDG PET-CT is useful for differentiating between sclerosing mesenteritis and malignant mesenteric involvement.
  • #12 RSNA 2021 – CTisus.com CT Scanning
    https://ctisus.com/learning/exhibit/gastrointestinal/333633
    CT of Sclerosing Mesenteritis: A Challenging Diagnosis […] Sclerosing mesenteritis is a rare inflammatory condition of unknown cause that affects the root of the mesentery. The mesenteric fat is involved with a variable amount of inflammation, fatty necrosis, and fibrosis. When the inflammation predominates (so-called mesenteric panniculitis), patients generally present with acute pain. On CT images, mesenteric panniculitis appears as a focal area of increased attenuation within the mesenteric fat surrounded by a pseudocapsule, an appearance that has been described as „the misty mesentery”. Areas of fibrosis within the inflamed fat appear as linear bands of soft-tissue attenuation. […] Sclerosing Mesenteritis: CT Findings […] Retraction and shortening of small bowel mesentery […] Partial or complete SBO
  • #13 Sclerosing Mesenteritis-Update on Diagnostic and Therapeutic Appr
    https://www.itmedicalteam.pl/articles/sclerosing-mesenteritisupdate-on-diagnostic-and-therapeutic-approach-108510.html
    The most common finding is a nonspecific mass of soft tissue in the mesentery of the small intestine, which infiltrate the intestinal tissue. […] The ”greasy” ring signal (75-90% of cases) and the tumor pseudocapsule (50-60% of cases), are considered specific findings of this pathology. […] The diagnosis is established by histopathologic study, being the essential biopsy and mandatory on all suspected cases. […] Histologically, the disease progresses in three stages. […] Some studies suggest diagnostic criteria based on radiological and histopathological findings: a) injuries with fat density that configure single, multiple or diffuse masses; b) histological confirmation of fat necrosis with inflammatory infiltrate and/or infiltration by macrophages; c) no evidence of inflammatory bowel disease, pancreatitis or extra-abdominal fat necrosis (suggestive of Weber-Christian disease).
  • #14 RSNA 2021 – CTisus.com CT Scanning
    https://ctisus.com/learning/exhibit/gastrointestinal/333633
    Well defined or ill-defined mesenteric mass with soft tissue or mixed fat and soft tissue attenuation […] May encase mesenteric vessels with preservation of fatty collar around the vessels (fat ring sign) […] Punctate or coarse calcifications may be seen. […] Sclerosing Mesenteritis: Differential Diagnosis […] Carcinoid tumor […] Metastatic disease to mesentery […] Lymphoma […] Soft tissue sarcomas […] Weber Christian disease.
  • #15 Sclerosing mesenteritis and mesenteric panniculitis – clinical experience and radiological features | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-017-0632-7
    Sclerosing mesenteritis (SM) is sometimes used as an umbrella-term for idiopathic inflammatory conditions in the mesentery. […] The diagnosis is based on histopathology or radiology. Histology was the most reliable diagnostic tool earlier and was considered as the standard for diagnosis and has been used in some major clinical studies. […] The suggestion by Emory et al. that MP is a subgroup of SM has not been questioned. […] The medical records were reviewed and if the diagnosis could be confirmed with histology or radiology, the patients were included. […] Sclerosing mesenteritis was considered histologically confirmed if the pathologist suggested SM or if the clinician concluded the inflammatory changes consistent with SM. […] A subgroup of four patients with mesenteric inflammation and histologically verified SM were identified.
  • #16 Sclerosing mesenteritis and mesenteric panniculitis – clinical experience and radiological features | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-017-0632-7
    Although they had extensive radiological findings they did not fulfill the Coulier criteria for MP. […] The term SM was reserved for these patients. […] Atypical radiology with histopathology compatible with SM may represent a separate entity with a more aggressive clinical course. […] We propose that the term SM should be reserved for this condition.
  • #17 Ultrasonography-based Management of Sclerosing Mesenteritis | IMCRJ
    https://www.dovepress.com/ultrasonography-based-management-of-sclerosing-mesenteritis-from-diagn-peer-reviewed-fulltext-article-IMCRJ
    Regarding the imaging features, the detection at CT scan of an increase in the mesenteric fat density, named misty mesentery, should be considered the first indication, but non-specific mark of SM. […] Furthermore, US and magnetic resonance imaging (MRI) have also been performed for the diagnosis of SM, but there are fewer studies for these procedures than CT and lack of standardized criteria. […] In conclusion, US could be a sensitive, reliable and non-invasive procedure for the diagnosis and the follow-up of SM.
  • #18 Idiopathic sclerosing mesenteritis – Wikipedia
    https://en.wikipedia.org/wiki/Idiopathic_sclerosing_mesenteritis
    In regards to the diagnosis of idiopathic sclerosing mesenteritis, a CT scan which creates cross-section pictures of the affected individuals body, can help in the assessment of the disease. „Misty mesentery” is often used to describe increase in mesenteric fat density in sclerosing mesenteritis. However, it is not specific and can be found in other conditions such as mesenteric oedema, lymphedema, haemorrhage, and presence of neoplastic and inflammatory cells must be excluded. Mesenteric lymph nodes are rarely larger than 10 mm in sclerosing mesenteritis. Larger lymph nodes should prompt further investigations with PET scan or biopsy.[7] […] MRI scan may show an intermediate T1 intensity and variable T2 intensity depending on degree of oedema and fibrosis. Presence of oedema causes high T2 signal while fibrosis causes low T2 signal.[7] […] It often mimics other abdominal diseases such as pancreatic or disseminated cancer.[8] CT scanning is important for making the initial diagnosis.[9]
  • #19 Sclerosing mesenteritis | Applied Radiology
    https://appliedradiology.com/articles/sclerosing-mesenteritis
    Another finding that may be observed in sclerosing mesenteritis is the presence of a pseudocapsule surrounding the affected mesentery, seen as a soft tissue density band. […] In suggesting the diagnosis of sclerosing mesenteritis, the absence of factors (such as metastasis, multiple tumor sites, or elevated levels of 5-hydroxyindoleacetic acid in urine, as seen in carcinoid), may aid in narrowing the differential diagnosis. […] The sonographic appearance of sclerosing mesenteritis has been reported as a heterogeneous mass with predominance of both hypoechoic and hyperechoic features. […] Histopathologically, lipid-laden macrophages, known as lipophages, are seen. […] In most cases, the disease has a self-limited course with complete resolution. […] However, it is very difficult to diagnose this entity preoperatively.
  • #20 Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma | World Journal of Surgical Oncology | Full Text
    https://wjso.biomedcentral.com/articles/10.1186/s12957-017-1214-4
    The results of recently published studies indicate that PET scan findings enable clinicians to differentiate between benign and neoplastic mesenteric processes. […] The prognosis of sclerosing mesenteritis is generally regarded as favorable with supportive treatment. […] In conclusion, it is necessary to excise and examine mesenteric nodules in patients with a history of malignancy to distinguish tumor recurrence from alternative diagnoses, such as sclerosing mesenteritis. […] Sclerosing mesenteritis can mimic peritoneal metastasis from malignancies, and it is necessary to excise and examine a mesenteric nodule developing in patients with a history of malignancy to distinguish recurrence and differential diagnosis such as sclerosing mesenteritis.
  • #21 Sclerosing mesenteritis: a comprehensive clinical review
    https://atm.amegroups.org/article/view/20473/html
    Although no definitive gross pathologic criteria have been defined, Kipfer et al. proposed the sclerosing mesenteritis to have three gross pathological clinical categories. […] Given the broad differential and the similar imaging findings of several neoplastic processes, a significant number of patients usually undergo CT guided biopsy to establish the diagnosis. […] A significant variety of medical interventions have been used and reported in the literature to treat this challenging diagnosis.
  • #22 Sclerosing mesenteritis as an unusual cause of fever of unknown origin: a case report and review | Clinics
    https://www.elsevier.es/en-revista-clinics-22-articulo-sclerosing-mesenteritis-as-an-unusual-S1807593222018683
    Sclerosing mesenteritis is a rare idiopathic condition characterized by a non-neoplastic inflammatory process in the mesenteric fat. […] The clinical presentation and radiological findings are nonspecific, which renders the condition a diagnostic challenge for surgeons and internists. […] Granulomatous and neoplastic diseases are part of the differential diagnosis for sclerosing mesenteritis on clinical and radiological grounds. […] Therefore, histopathology remains the main diagnostic tool. […] The histological findings are fibrosis, myofibroblasts, and inflammatory cell infiltration of the fatty tissue with degeneration or fat necrosis; aggregations of lipid-laden foamy macrophages are also present. […] The likely causal relationship of the disease and FUO in this case is supported by the lack of any other diagnosis, the confirmatory histological findings of sclerosing mesenteritis, and the remission of fever with nonsteroidal anti-inflammatory drug use and the surgical removal of involved tissue.
  • #23 Sclerosing mesenteritis | Applied Radiology
    https://appliedradiology.com/articles/sclerosing-mesenteritis
    The diagnosis is made depending on the extent to which inflammatory or fibrotic components predominate. […] The acute or subacute phase of the disease is termed panniculitis, where fatty degeneration and inflammation is the predominant feature. […] The chronic form, termed retractile mesenteritis, is considered when fibrosis is the dominant feature. […] Myriad CT presentations have been described for sclerosing mesenteritis. […] The typical description includes the presence of a heterogeneous mesenteric mass of soft tissue attenuation, with fibrotic or cystic components. […] Based on CT findings, the differential diagnosis for sclerosing mesenteritis, besides carcinoid tumor, includes carcinomatosis, mesenteric lymphoma, and desmoid tumor. […] The fat-ring sign in cases of panniculitis has been described to aid in differentiating sclerosing mesenteritis from other entities.
  • #24 Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma | World Journal of Surgical Oncology | Full Text
    https://wjso.biomedcentral.com/articles/10.1186/s12957-017-1214-4
    Sclerosing mesenteritis is a non-neoplastic inflammatory disease that occurs in the bowel mesentery. Distinguishing sclerosing mesenteritis from neoplasms may be difficult because of the clinical and radiographic similarities between the two disease entities. […] In patients suspected of having localized peritoneal metastasis from malignancies, any masses must be sampled by surgical excisional biopsy and subsequently examined to rule out alternative diagnoses, such as sclerosing mesenteritis. […] Sclerosing mesenteritis is sometimes indistinguishable from neoplasms because its manifestations and radiographic findings may be identical to those of malignancies. […] Despite these similarities, sclerosing mesenteritis is treated very differently than malignancies; thus, it is very important that sclerosing mesenteritis is diagnosed correctly so that the disease can be managed adequately.
  • #25 Sclerosing Mesenteritis | Abdominal Key
    https://abdominalkey.com/sclerosing-mesenteritis/
    A definite diagnosis of SM can only be made by biopsy and pathologic analysis; however the incidental and often asymptomatic nature does not justify biopsy in most cases. Diagnosis can be made by imaging features, especially CT examination (see Sect. 11.8). The term SM is solely reserved for idiopathic inflammation leading to infiltration of the mesentery and must be differentiated from any alternative causes altering density of the mesenteric fat (misty mesentery) [24, 37, 52, 56, 58]. This includes mesenteric edema, hemorrhage, inflammation (e.g., pancreatitis and other inflammatory diseases of the gastrointestinal tract), retroperitoneal fibrosis (RPF), and neoplasm involving the mesentery including lymphoma and primary mesenteric neoplasm. When fibrosis dominates in SM, imaging features may overlap with carcinoid tumors, desmoid tumors, and peritoneal carcinomatosis. Lymphoma is the most common tumor involving the mesentery and is a challenging differential diagnosis to exclude, particularly in the early stage when bulky lymphadenopathy may still be absent [24, 37]. The halo sign and pseudocapsule favors SM, but can be seen in lymphoma. Any lymphadenopathy outside the mesenteric regions favors early stage lymphoma. Lymphoma will not contain calcifications, unless previously treated [24]. The CT appearance of SM and carcinoid can be identical. Both can appear as an infiltrating mass in the root of the mesentery with desmoplastic reaction and calcifications [7, 23, 24]. The halo sign favors SM, a discrete enhancing bowel mass and hypervascular liver metastases favor carcinoid tumor.
  • #26 Frontiers | Sclerosing Mesenteritis, a Rare Cause of Mesenteric Mass in a Young Adult: A Case Report
    https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2021.722312/full
    Sclerosing mesenteritis (SM) is a rare fibroinflammatory disorder that involves mesenteric adipose tissue, more frequently localized in the small intestine, with an insidious clinical presentation having symptoms related to mass effect, usually resulting in bowel obstruction, mesenteric ischemia, as well as rapid weight loss. […] The diagnosis of sclerosing mesenteritis was made. Our case emphasizes that histology remains pre-eminent for a correct diagnosis of SM, as pre-operative radiological-based diagnosis is non-specific. […] There are no specific laboratory tests for SM; in most of these patients there is an increase in inflammation indices, such as erythrocyte sedimentation (ESR) rate and c-reactive protein (CRP). […] Despite the improvement in imaging methods, the histological evaluation of biopsy and surgical samples remains the gold standard for the diagnosis of SM. […] The main differential diagnoses of SM revolve around GIST (gastrointestinal stromal tumor) and mesenteric fibromatosis. […] Our case emphasizes that histology remains prominent for a correct diagnosis of SM, as preoperative radiological-based diagnosis is non-specific.
  • #27 Treatment options for spontaneous and postoperative sclerosing mesenteritis
    https://www.wjgnet.com/1948-9366/full/v8/i11/761.htm
    Sclerosing mesenteritis is a rare pathology with only a few described cases in the literature. The etiology is unclear; however, several potential triggers, including abdominal surgery and abdominal trauma, have been discussed. […] Despite it being a rare disease, sclerosing mesenteritis is an important differential diagnosis in patients after abdominal surgery or patients presenting spontaneously with signs of acute inflammation and abdominal pain. […] The symptoms of sclerosing mesenteritis are mostly unspecific. Hence, it is crucial to rule out other pathologies such as lymphoma, sarcoma, peritoneal mesothelioma, infectious diseases (tuberculosis or histoplasmosis) or amyloidosis. […] Due to the nonspecific clinical presentation, a surgical biopsy is often performed; however, it is rarely actually necessary.
  • #28 Idiopathic Sclerosing Mesenteritis: An Extremely Rare Cause of Mesenteric Mass | Dhruv | Journal of Medical Cases
    https://www.journalmc.org/index.php/JMC/article/view/3825/3177
    Overall, most patients will improve over time and if it is secondary to autoimmune conditions, the treatment of the autoimmune condition improves the inflammation in the mesentery. […] Idiopathic sclerosing mesenteritis is a diagnosis of exclusion after ruling out some important causes like autoimmune diseases and malignancy and is usually confirmed by tissue diagnosis. […] Further research is needed to establish the etiology of the disease and proper treatment protocols including medical vs. surgical management and their respective outcomes.
  • #29 Treatment options for spontaneous and postoperative sclerosing mesenteritis
    https://www.wjgnet.com/1948-9366/full/v8/i11/761.htm
    Today, based on the increasing use of ultrasonography and CT scan with improved quality, the diagnosis can be established based on imaging and clinical presentation. […] Clinical manifestations are nonspecific and can consist of abdominal pain (70%), diarrhea (25%), weight loss (23%), abdominal muscle defense (50%), rebound tenderness (10%-15%), ascites/chylous (14%) and, in rare cases, fever. […] The only evidence in the treatment of these patients is that, in the case of non-resolving bowel obstruction, surgery is needed. […] However, the symptomatic sclerosing mesenteritis must be treated surgically or with a trial of immunosuppressive medication.
  • #30 Sclerosing Mesenteritis: Symptoms, Causes & Diagnosis
    https://tap.health/sclerosing-mesenteritis-symptoms/
    Symptoms can be varied and often mimic other gastrointestinal issues, making diagnosis challenging. […] Early diagnosis is key to successful treatment. […] Diagnosis often involves imaging techniques like CT scans and MRI scans to visualize the thickened mesentery. […] In the Indian subcontinent and other tropical regions, access to advanced imaging and surgical care can be a challenge; therefore, proactive healthcare engagement is crucial. […] Early recognition is crucial for optimal management. […] Diagnosis relies heavily on imaging techniques such as CT scans and MRI, which help visualize the characteristic fatty deposits and inflammation in the mesentery. […] Access to specialized surgical care is a key factor influencing outcomes, particularly in regions with limited healthcare infrastructure.
  • #31 Sclerosing Mesenteritis: Symptoms, Causes & Diagnosis
    https://tap.health/sclerosing-mesenteritis-symptoms/
    Early diagnosis and access to appropriate healthcare significantly improve the prognosis for sclerosing mesenteritis in India and other tropical countries. […] Early and accurate diagnosis is critical for appropriate management, improving patient outcomes and quality of life. […] Prompt medical attention ensures that you receive the correct treatment and prevent potential complications.